Adjuvants are indispensable components of vaccines. Despite being widely used in
vaccines, their action mechanisms are not yet clear. With a greater understanding of the …

Responsible for more than 4.9 million deaths so far, COVID-19, caused by SARS-CoV-2, is
instigating devastating effects on the global health care system whose impacts could be …

Abstract Coronavirus disease 2019 (COVID-19) is caused by a new member of the
Coronaviridae family known as severe acute respiratory syndrome coronavirus 2 (SARS …

The receptor-binding domain (RBD) of the protein S SARS-CoV-2 is considered to be one of
the appealing targets for developing a vaccine against COVID-19. The choice of an …

In the post-COVID-19 pandemic era, the new global situation and the limited therapeutic
management of the disease make it necessary to take urgent measures in more effective …

Since the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and
its resultant pneumonia in December 2019, the cumulative number of infected people …

Monkeypox (mpox) is a zoonotic infectious disease caused by the mpox virus. Mpox
symptoms are similar to smallpox with less severity and lower mortality. As yet mpox virus is …

At this present stage of COVID-19 re-emergence, designing an effective candidate vaccine
for different variants of SARS-CoV-2 is a study worthy of consideration. This research used …

Background Adjuvants are chemical or biological materials that enhance the efficacy of
vaccines. A-910823 is a squalene-based emulsion adjuvant used for S-268019-b, a novel …

The variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are more
transmissible, with a reduced sensitivity to vaccines targeting the original virus strain …